Dong Lyu
Director/Board Member at GENOR BIOPHARMA HOLDINGS LIMITED
Dong Lyu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENOR BIOPHARMA HOLDINGS LIMITED | Director/Board Member | 2021-11-01 | - |
| LUYE PHARMA GROUP LTD. | Director/Board Member | 2023-12-05 | - |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 2020-09-29 | - |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 2020-08-31 | - |
Career history of Dong Lyu
Former positions of Dong Lyu
| Companies | Position | Start | End |
|---|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Director/Board Member | 2020-11-29 | 2023-08-30 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Board Member | 2021-03-15 | 2022-10-27 |
| KEYMED BIOSCIENCES INC. | Director/Board Member | 2021-03-02 | 2022-03-28 |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | 2016-08-31 | 2020-08-31 |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 2011-06-30 | 2016-06-30 |
| ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Dong Lyu
| Beijing Medical University | Undergraduate Degree |
| China Pharmaceutical University | Doctorate Degree |
| Peking University | Graduate Degree |
Statistics
International
| China | 9 |
| Cayman Islands | 4 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 6 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| KEYMED BIOSCIENCES INC. | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
| LUYE PHARMA GROUP LTD. | Health Technology |
| Private companies | 5 |
|---|---|
| Shanghai Panxin Equity Investment Management Co. Ltd. | |
| Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
| Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
| Zhuhai Gao Ling Equity Investment Management Co. Ltd. |
- Stock Market
- Insiders
- Dong Lyu
- Experience
